-
Condom test piece tearing force and elongation at break tester PLC operating system control a set of Shanghai Chengwei
Time of Update: 2022-09-07
Within 80mm from the open end of the condom, the two sides are parallel and there is no texture, and one impact cut the test piece .
-
For rheumatoid arthritis, don’t only care about inflammation, and osteoporosis should not be underestimated
Time of Update: 2022-08-16
The activity of cells and osteocytes adversely affects bone remodeling Glucocorticoids are a class of drugs that are widely used clinically in patients with rheumatoid arthritis.
Reducing the activity of osteoblasts and osteocytes adversely affects bone remodeling Glucocorticoids are a class of drugs that are used more clinically in patients with rheumatoid arthritis.
-
Circular of Sichuan Provincial Market Supervision and Administration Bureau on Food Safety Supervision and Sampling Inspection (No. 2 of 2022
Time of Update: 2022-01-22
Recently, the Provincial Market Supervision and Administration Bureau organized food safety supervision and sampling inspections , and extracted 66 batches of 7 categories of food including food additives , meat products , alcohol , edible oil , grease and its products, starch and starch products , condiments , tea and related products.
-
The physical and chemical properties and application of polyvinylamine
Time of Update: 2021-10-21
Consistent with other strong alkaline substances, polyvinylamine and its aqueous solution should avoid contact with carbon dioxide in the atmosphere, and it is best to make polymer hydrochloride for storage .
-
"Golden Nine" cut off supply caused chemical companies to increase prices
Time of Update: 2021-09-12
15 / Pound (about 2138 yuan / ton); the price of styrene acrylic dispersion increased by 0.
On this basis, starting from September 15th, or as permitted by the contract, BASF's dispersion and resin business will implement new price increases .
-
FDA approves PHASE III clinical trial of AMZ002 for the treatment of epilepsy in infants
Time of Update: 2020-12-22
Infant epilepsy can lead to delayed overall neurodevelopment, severe intellectual disability, limited treatment options and poor prognosis.
pharmaceutical company AMZELL recently announced that it has concluded discussions with the FDA and will conduct a Phase III clinical trial of AMZ002 to treat epilepsy in infants.
-
Lancet oncol: The efficacy of the PARP inhibitor veliparib in the treatment of advanced breast cancer with BRCA mutations
Time of Update: 2020-09-23
in the BROCADE3 trial, the researchers compared the efficacy of veliparib and placebo combined carbotin and yew alcohol treatment for her2-negative advanced breast cancer patients with BRCA1 or BRCA2 embryonic mutations.
